IceCure Medical Kicks Off its Post-Marketing "ChoICE" Study for the Low-Risk Breast Cancer Treatment at First U.S Clinical Site

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. SPY
2. WBD
3. PSKY
4. NVDA
5. TSLA
6. USO
7. AMD
8. META
9. AMC
10. COHR

Go back to IceCure Medical Kicks Off its Post-Marketing "ChoICE" Study for the Low-Risk Breast Cancer Treatment at First U.S Clinical Site
(NASDAQ: ICCM) Delayed: 1.95 -0.01 (0.51%)
Previous Close $1.96    52 Week High $ 
Open $1.99    52 Week Low $ 
Day High $2.08    P/E N/A 
Day Low $1.95    EPS $ 
Volume 70,959